Skip to main content

Find Clinical Trials

Home
Conditions
Urinary Bladder Diseases

Clinical trial condition

Urinary Bladder Diseases

Explore clinical trials studying Urinary Bladder Diseases. Study availability and eligibility vary by location and protocol.

2,289 public trials 414 recruiting studies

Refine in advanced search Browse all conditions

Urinary Bladder Diseases trial results

Completed

An Educational Intervention for Patients With Bladder Cancer

NCT01915121

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Icahn School of Medicine at Mount Sinai New York, United States

James J. Peters VA Medical Center The Bronx, New York, United States

View Trial Details

Completed

Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)

NCT02080650

Conditions: Adenocarcinoma, Advanced MET Amplified Solid Tumor, Bladder Cancer, +51 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Urinary Biomarkers For Objective Measurement Of InterStim® Response In Over Active Bladder (OAB) Patients.

NCT01739946

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations: William Beaumont Hospital Royal Oak, Michigan, United States

View Trial Details

Completed

A Comparison of Electrical Ilioinguinal Nerve Stimulation With Intravesical Irrigation for Bladder Pain Syndrome

NCT02856022

Conditions: Cystitis, Cystitis, Interstitial, Female Urogenital Diseases, +6 more
Locations: Shanghai research institute of acupuncture and meridian Shanghai, China

View Trial Details

Completed

Prediction of Impaired Survival in Elderly Bladder Cancer Patients Opting for Radical Cystectomy

NCT02039310

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

Intravesical Administration of rAd-IFN/Syn3 in Patients With BCG-Refractory or Relapsed Bladder Cancer

NCT01687244

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Not specified

View Trial Details

Completed

Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer

NCT00380029

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Completed

Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871

NCT01015963

Conditions: Bladder Cancer, Breast Cancer, Breast Diseases, +50 more
Locations: Not specified

View Trial Details

Completed

Efficacy Study of Adding Chemotherapy to Radiotherapy for Treating Bladder Cancer.

NCT00330499

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations: Liverpool Hospital Liverpool, New South Wales, Australia

Calvary Mater Newcastle Newcastle, New South Wales, Australia

Nepean Cancer Care Centre Penrith, New South Wales, Australia

Prince of Wales Hospital Randwick, New South Wales, Australia

View all 22 locations

View Trial Details

Completed

Cancer in Patients With Gabapentin (GPRD)

NCT01236053

Conditions: Adenocarcinoma, Anal Cancer, Anus Diseases, +82 more
Locations: Not specified

View Trial Details